AI-aided colonoscopy improves ADR

Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds

A Mayo Clinic has developed an artificial intelligence model that can help specialists detect pancreatic cancer on routine abdominal CT scans up to three years before clinical diagnosis. It identifies subtle signs of disease before tumors are visible, when curative treatment may still be possible.

May 01, 2026

Vol.52 No.17

Drugs & Targets

Unfold AI’s prostate cancer mapping added to regional CMS Physician Fee Schedule

Unfold AI, an AI prostate cancer mapping and clinical decision support platform, is now included in Medicare’s Physician Fee Schedules across the West Coast and Mountain West regions. The regional expansion of Medicare payment for the tool gives urologists and care teams clearer reimbursement pathways in physician office settings, an area that has historically lagged behind hospital outpatient settings for emerging technologies.

May 01, 2026

Vol.52 No.17

In Brief

UT Austin announces first tech-native academic medical center in the U.S.

The University of Texas at Austin is building an integrated academic medical center from the ground up, where care, research, and education operate as one system organized around the patient. This model connects prevention, diagnosis, treatment, and long-term health into a continuous experience, particularly for those with complex and serious conditions.

April 24, 2026

Vol.52 No.16

In Brief

Lisa Eli named chief scientific officer at Zephyr AI

Lisa Eli has been appointed chief scientific officer at Zephyr AI Inc.

April 24, 2026

Vol.52 No.16

Clinical Roundup

Johns Hopkins-led study shows how bacterial toxin drives colon tumor formation

A multicenter research team led by Johns Hopkins Medicine have identified a protein called claudin-4 that binds to the B. fragilis toxin receptor, a toxin which is known to drive colon tumor formation.

April 24, 2026

Vol.52 No.16

In Brief

Myriam Chalabi wins the grand prize for Innovators in Science Award by Takeda and Nature

Takeda and Nature announced the grand prize winner for the 2026 Innovators in Science Award—Myriam Chalabi, a medical oncologist at the Netherlands Cancer Institute.

April 17, 2026

Vol.52 No.15

AI-aided colonoscopy improves ADR

YOU MAY BE INTERESTED IN

Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds

Unfold AI’s prostate cancer mapping added to regional CMS Physician Fee Schedule

UT Austin announces first tech-native academic medical center in the U.S.

Lisa Eli named chief scientific officer at Zephyr AI

Johns Hopkins-led study shows how bacterial toxin drives colon tumor formation

Myriam Chalabi wins the grand prize for Innovators in Science Award by Takeda and Nature

Renew today!

Subscriber content

Never miss an issue!

Login